Cantor Fitzgerald analyst Sarah James initiated coverage of UnitedHealth with an Overweight rating and $591 price target. Heading into an election cycle in a cost-inflationary environment makes the company’s features of innovation, ROIC, and risk diversification even more valuable, the analyst tells investors in a research note. UnitedHealth will continue to be on the forefront of pushing value-based care on the payor, provider, and enablement technology fronts, which should drive its earnings growth over the next few years, the firm added.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on UNH:
- UnitedHealth management to meet virtually with Oppenheimer
- UnitedHealth price target raised to $627 from $617 at Deutsche Bank
- UnitedHealth price target lowered to $562 from $596 at TD Cowen
- UnitedHealth price target raised to $600 from $590 at Loop Capital
- Rob Arnott Says It’s Time to Buy Into Value Stocks; Here Are 2 Names That Analysts Like